Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified non-coding mutations in pancreatic ductal adenocarcinoma (PDAC) using whole-genome sequencing. They found ZFP36L2 acts as a tumor suppressor gene, offering new insights into PDAC development.
Area Of Science
- Genomics
- Cancer Biology
- Molecular Oncology
Background
- Identifying non-coding somatic mutations driving cancer is difficult.
- Pancreatic ductal adenocarcinoma (PDAC) is a complex malignancy with many genetic alterations.
- Understanding the non-coding genome's role in PDAC is crucial for targeted therapies.
Purpose Of The Study
- To comprehensively characterize non-coding driver mutations in pancreatic ductal adenocarcinoma (PDAC).
- To identify novel genes and regulatory mechanisms involved in PDAC pathogenesis.
Main Methods
- Whole-genome sequencing of PDAC samples.
- Genome-scale mapping of accessible regulatory regions in pancreatic tissues.
- Analysis of mutation enrichment in regulatory elements.
- Functional validation using chromatin interaction, reporter assays, and CRISPR interference.
Main Results
- Created genome-wide maps of accessible chromatin and histone modifications in pancreatic cells.
- Identified 314 regulatory regions enriched with 3614 non-coding somatic mutations (NCSMs) in 506 PDACs.
- 178 NCSMs affected reporter gene activity, with 19.45% of tested mutations showing impact.
- Confirmed ZFP36L2 as a target gene affected by NCSMs, with ZFP36L2 overexpression inhibiting tumor growth, suggesting a tumor suppressor role.
Conclusions
- An integrative approach identified potential non-coding driver mutations in PDAC.
- ZFP36L2 is nominated as a novel PDAC driver gene with a probable tumor suppressor function.
- This study provides a catalog of non-coding mutations and highlights ZFP36L2's significance in PDAC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...